Sparrow Quantum, a leading European supplier of photonic quantum chips, has secured €21.5 million in Series A funding to accelerate the development and commercialization of its world-leading quantum chip technology. The investment round was led by PensionDanmark, with strong backing from EIFO and Novo Holdings and additional investments from existing
MicroLub a University of Leeds spinout has developed a new ingredients technology that: Replaces fats and oils with water without losing the sensory food experience Addresses key consumer demands for lower-calorie and sustainable food options Targets dairy and plant-based food and food ingredients markets 21st October 2024 - Northern Gritstone,
Evoralis is developing innovative enzymes that can break down even the toughest mixed and blended fibers, paving the way for a truly circular economy in textiles. Evoralis, a pioneering company specializing in the discovery and development of plastic-depolymerizing enzymes, has raised £2.5M in a Seed funding round. This investment marks
Evergreen Theragnostics, a clinical-stage radiopharmaceutical company, today announced the successful completion of a $26M capital raise supported both by existing shareholders and new institutional investors, Petrichor and LIFTT. The financing advances Evergreen’s novel discovery pipeline into clinical trials, supports commercialization of its diagnostic agent, and further expands CDMO capabilities to
NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announces a further extension of £9.6m (approx. USD $12.2m) to its Series B financing round. With participation from its existing syndicate, CPF managed by Sixth Element Capital, Claris Ventures, Astellas Venture Management, 3B Future Health Fund, 2investAG, and the addition of three
1000Farmacie, the leading Italian pharmacy marketplace, announced today the successful completion of its second tranche of Series A funding, raising a total of $25 million. The company secured an additional $10 million in the extension round, highlighting investor confidence and further accelerating the company's mission to revolutionize the pharmaceutical industry.
Easyrain is undergoing a capital increase and preparing for collaborations with a Tier-1 company and an automotive manufacturer. Barely we had time to tone down the enthusiasm from the successful participation in the Goodwood Festival of Speed, and it's already time to announce a new and significant milestone: Easyrain announces
Copenhagen, Denmark - Sparrow Quantum Aps., a quantum technology company based in Denmark, announced today that it had secured 31 million DKK (€4.1m) in seed funding, the largest investment to date in a Danish quantum technology company. The funding round was led by the venture capital firm 2xN and includes
LIFTTand the Venture Capital fund set up by the European Commission (EC) bet on artificial intelligence used in the professional dubbing sector, a 10-billion-dollar market. The evergreen Venture Capital Holding LIFTT—as lead Investor—and the European Innovation Council Fund (EIC Fund) are investing 1 million euros in Voiseed, the Italian
“The innovation made by Careglance allows for a much faster surface analysis speed as well as considerably reducing the size of the OCT device.” LIFTT is participating with a EUR 250,000 investment in Care Glance, a deep tech start-up operating in the field of micro-optical diagnostics, which has developed and
VAT n. 12013790014
Shared Capital
€ 100.835.954,00 authorised,
€ 43.482.552,00 paid,
€ 40.000.000,00 as per last statutory financial statements.
LIFTT S.p.A. adopts an Organization, Management and Control Model in line with the provisions of Legislative Decree 231/2001, and the Code of Ethics as completing part of the Model.